Rafferty Asset Management’s Jazz Pharmaceuticals JAZZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$342K Sell
3,226
-239
-7% -$25.4K ﹤0.01% 957
2025
Q1
$430K Sell
3,465
-855
-20% -$106K ﹤0.01% 901
2024
Q4
$532K Sell
4,320
-1,137
-21% -$140K ﹤0.01% 896
2024
Q3
$608K Buy
5,457
+326
+6% +$36.3K ﹤0.01% 892
2024
Q2
$548K Buy
5,131
+815
+19% +$87K ﹤0.01% 928
2024
Q1
$520K Buy
4,316
+914
+27% +$110K ﹤0.01% 966
2023
Q4
$418K Buy
3,402
+705
+26% +$86.7K ﹤0.01% 1007
2023
Q3
$349K Buy
2,697
+170
+7% +$22K ﹤0.01% 998
2023
Q2
$313K Buy
2,527
+561
+29% +$69.5K ﹤0.01% 1035
2023
Q1
$288K Sell
1,966
-222
-10% -$32.5K ﹤0.01% 1047
2022
Q4
$349K Buy
2,188
+276
+14% +$44K ﹤0.01% 973
2022
Q3
$255K Buy
1,912
+27
+1% +$3.6K ﹤0.01% 1042
2022
Q2
$294K Sell
1,885
-1,257
-40% -$196K ﹤0.01% 921
2022
Q1
$489K Sell
3,142
-4,380
-58% -$682K ﹤0.01% 1005
2021
Q4
$958K Buy
7,522
+1,829
+32% +$233K 0.01% 882
2021
Q3
$741K Sell
5,693
-129
-2% -$16.8K 0.01% 952
2021
Q2
$1.03M Buy
5,822
+297
+5% +$52.7K 0.01% 879
2021
Q1
$908K Sell
5,525
-233
-4% -$38.3K 0.01% 792
2020
Q4
$950K Buy
5,758
+410
+8% +$67.6K 0.01% 515
2020
Q3
$763K Buy
5,348
+2,441
+84% +$348K 0.01% 618
2020
Q2
$321K Buy
+2,907
New +$321K ﹤0.01% 812
2020
Q1
Sell
-11,630
Closed -$1.74M 704
2019
Q4
$1.74M Buy
11,630
+7,682
+195% +$1.15M 0.03% 432
2019
Q3
$506K Buy
3,948
+1,847
+88% +$237K 0.01% 660
2019
Q2
$300K Buy
+2,101
New +$300K 0.01% 747